BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3878887)

  • 1. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
    Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
    J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of low molecular weight material in cellular immune complex assays.
    Cooper KM; Moore M
    Clin Exp Immunol; 1983 May; 52(2):407-16. PubMed ID: 6602679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of circulating immune complexes in chronic lung diseases.
    Cooper KM; Moore M
    J Clin Lab Immunol; 1982 Apr; 7(3):155-61. PubMed ID: 6980284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
    Scullion M; Balint G; Whaley K
    J Clin Lab Immunol; 1979 Apr; 2(1):15-22. PubMed ID: 95801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
    Poulton TA; Mooney NA; Nineham LJ; Hay FC
    Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
    Kilgallon W; Amlot PL; Williams BD
    Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
    Soltis RD; Hasz DE
    J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
    Caillot G; Lamelin JP; Hartmann DJ; Ville G
    Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
    J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of circulating immune complexes in normal subjects using four different methods.
    Di Mario U; Guy K; Irvine WJ
    J Clin Lab Immunol; 1981 Mar; 5(2):95-9. PubMed ID: 6971334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic liver disease: the detection and characterization of circulating immune complexes.
    Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
    Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
    Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
    J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the soluble immune complexes that are detected by three different techniques.
    van der Giessen M; The TH
    Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
    Belozerov AP
    Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune complexes in normal subjects.
    Simpson IJ; Myles MJ; Smith GW
    J Clin Lab Immunol; 1983 Jul; 11(3):119-22. PubMed ID: 6350590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.